(Press-News.org) Weill Cornell Medicine has received a three-year, nearly $6 million grant to lead one of three national contraceptive research centers. The grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health, will fund the Weill Cornell Medicine Contraception Development Research Center. Led by Drs. Jochen Buck and Lonny Levin, both professors of pharmacology at Weill Cornell Medicine, the center will focus on developing an on-demand male contraceptive.
“It’s an honor to be selected for a second time for this award,” Dr. Levin said. “It will help us take the next steps in the years-long process of bringing a new contraceptive option to the public.”
Currently, females have many contraceptive options available to them, including taking hormonal pills or having an intrauterine device inserted, though they are often poorly tolerated or inconvenient. The only male contraceptive options are condoms or vasectomies. But a study published by Dr. Buck and Levin earlier this year in Nature Communications demonstrated that a single dose of a drug candidate that inhibits an enzyme called soluble adenylyl cyclase (sAC) immobilizes sperm for up to two and a half hours and prevents pregnancy in mice.
“Our idea is to develop a new form of on-demand contraception,” Dr. Buck explained. “The man takes the pill a half hour before having sex and then will be protected from impregnating someone for eight to twelve hours. Afterwards his fertility returns to normal.”
The funding from the Contraceptive Development Research Center Program at NICHD will help support three distinct projects to advance progress toward developing sAC inhibitor-based male contraceptives and an administrator to oversee the work.
One project will focus on improving the current drug candidate to make it suitable for humans. This candidate was developed and tested in a preclinical model in collaboration with the Sanders Tri-Institutional Therapeutics Discovery Institute (TDI), a relationship fostered by the Weill Cornell Medicine Enterprise Innovation office. The Sanders Tri-I TDI, led by Dr. Peter Meinke, works with investigators from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and The Rockefeller University to expedite early-stage drug discovery.
The second project will focus on developing additional compounds that have similar contraceptive effects. The third project will help the center test its compounds in a second preclinical model that more closely mimics human reproduction.
“We want to ensure that we’re starting with the best possible compound before we embark on clinical trials,” Dr. Levin said.
Many Weill Cornell Medicine physicians and scientists maintain relationships and collaborate with external organizations to foster scientific innovation and provide expert guidance. The institution makes these disclosures public to ensure transparency. For this information, see profiles for Dr. Levin and Dr. Buck.
The grant reported in this newsroom story was awarded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development under the Contraceptive Development and Research Center Program, federal award number P50HD113015-01.
END
NIH center grant bolsters male contraceptive research
2023-09-21
ELSE PRESS RELEASES FROM THIS DATE:
Supportive later-life social relationships mediate the risk of severe frailty in adults who had negative childhood experiences
2023-09-21
INDIANAPOLIS -- Frailty is a serious concern in later-life adults due to its association with additional health risks including disability, falls, hospitalization and mortality. The prevalence of frailty has risen over time; about 15 percent of those aged 65 years and older are considered frail.
In one of the first studies to analyze the mediating effects of social relationships in the relationship between childhood experiences and frailty, Regenstrief Research Scientist Monica M. Williams-Farrelly, PhD, has found ...
Towards a better understanding of early human embryonic development
2023-09-21
The onset of embryo-specific gene transcription, also known as embryonic genome activation (EGA), is a crucial step in the developmental journey of an organism. Although EGA has been studied to some extent in mice, human EGA remains largely unexplored, mainly due to the lack of novel in vitro cell models and ethical restrictions on the usage of human embryos. Thus, cell models resembling the human blastomere stage—when the embryo undergoes a cell duplication process—are necessary to study the earliest stages of human EGA and understand the events that occur during early embryonic development.
To ...
Evaluating the shear viscosity of different water models
2023-09-21
Water is one of the most abundant substances on Earth and partakes in countless biological, chemical, and ecological processes. Thus, understanding its behavior and properties is essential in a wide variety of scientific and applied fields. To do so, researchers have developed various water models to reproduce the behavior of bulk water in molecular simulations. While these simulations can provide valuable insights into the specific properties of water, selecting an appropriate model for the system under study is crucial. ...
Precision treatment for pneumonia care: metagenomic sequencing takes the lead
2023-09-21
Community-acquired pneumonia (CAP) is a major infectious disease worldwide and contributes to high mortality and massive economic burden. Hospital mortality among the severe CAP (SCAP) remains high, ranging from 25% to more than 50%.
Early identification of patients at high risk of death is essential for improving patient outcomes. However, predicting outcomes in patients with SCAP is challenging, as the disease is complex and influenced by various factors, including the types of pathogen causing the infection, the host immune response, and underlying medical conditions.
In this study published in eBioMedicine (a Lancet publication), a team led by Dr. Jinmin Ma, BGI Genomics Infection ...
Curiosity about religion is viewed as morally virtuous, new research finds
2023-09-21
People from diverse religious backgrounds in the United States view curiosity about religion as morally virtuous, according to new research published in Social Psychological and Personality Science. Atheists also view this curiosity as moral, although less moral than a lack of religious curiosity.
Previous research has examined what makes people curious and how curiosity helps people learn new information, but psychologists know less about how displaying curiosity is viewed by other people. The current research finds that people ...
Scholarships awarded to high school students committed to whole body wellness
2023-09-21
DALLAS, September 21, 2023 — Supporting the next generation of health advocates, the American Heart Association awards five high school seniors with $1,000 college scholarships to energize their commitment to community health through service-learning opportunities. The grants are a part of the American Heart Challenge™, a school-based program that helps middle and high school students feel good about their health, while doing good for the community.
The American Heart Association, devoted ...
Intra-lysosomal peptide assembly for the high selectivity Index against cancer
2023-09-21
A groundbreaking anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance has been developed by Professor Ja-Hyoung Ryu and his research team in the Department of Chemistry at UNIST. This pioneering research promises a new paradigm for chemical anticancer drugs in the future.
Lysosomes are crucial organelles responsible for breaking down and recycling cellular components. Targeting lysosomes with anticancer drugs has emerged as a promising approach to combat drug resistance in cancer cells. However, ...
Global policymakers call for effective infodemic management to be a substantive article in the pandemic accord
2023-09-21
(Toronto, September 21, 2023) The United Nations General Assembly held a high-level meeting on Pandemic Prevention, Preparedness, and Response on September 20, 2023, to continue discussions on finalizing a globally enforceable Pandemic Accord or Treaty that will be presented to the World Health Organization’s (WHO) World Health Assembly in May 2024. This treaty, if agreed to and eventually ratified, will be the second international treaty instrument under WHO auspices, and represents a critical juncture in global health needed to strengthen pandemic prevention, preparedness, and response in the ...
TTUHSC researchers receive NIH grant to address preeclampsia rates
2023-09-21
According to a study recently published by the Journal of the American Medical Association, maternal morbidity and mortality rates in Texas during the last two decades have more than doubled from 1999 (10.3 deaths per 100,000 births) to 2019 (21.9 deaths per 100,000 births). This rate not only exceeds the national average (17.4 in 2018), but it also places Texas at or near the bottom of most metrics used to determine the safest states in which to have a baby.
One of the primary factors related to the lack of maternity care in the Lone Star state is the existence of maternity care deserts, which are counties where no maternity care exists. And in the Texas Panhandle, ...
SBQuantum to test quantum magnetometer in space - designed to map Earth’s magnetic field
2023-09-21
SHERBROOKE, Canada (September 21, 2023) – SBQuantum, the first company developing diamond quantum magnetometers capable of providing vector measurements of both the amplitude and the orientation of Earth's magnetic field, today announces it has been selected as a participant in the final phases of the MagQuest Challenge, along with its partner, Spire Global.
Led by the U.S. National Geospatial-Intelligence Agency, MagQuest is a multi-million dollar competition to find more accurate and efficient ways to map the earth’s electromagnetic field, also known as the World Magnetic Model (WMM). Aircraft, ...